Binding of antibiotics by dialysis membranes and its clinical relevance.

Suppr

超能文献

作者信息

Rumpf K W, Rieger J, Ansorg R, Doht B, Scheler F

出版信息

Proc Eur Dial Transplant Assoc. 1977;14:607-9.

PMID:23529

Abstract

摘要

相似文献

Binding of antibiotics by dialysis membranes and its clinical relevance.

Proc Eur Dial Transplant Assoc. 1977;14:607-9.

Cellulosic ion-exchange membranes for hemodialysis.用于血液透析的纤维素离子交换膜。

J Biomed Mater Res. 1977 Jul;11(4):563-75. doi: 10.1002/jbm.820110411.

[Clinical study of the ultrafiltration properties of dialyzers and dialysis membranes].[透析器和透析膜超滤性能的临床研究]

Urol Nefrol (Mosk). 1982 Mar-Apr(2):28-32.

ASAHI hollow fiber kidney (ASAHI HFK) --- progress report.

Trans Am Soc Artif Intern Organs. 1974;20A:344-52.

[Regulation of ultrafiltration in plate and coil dialysis apparatus].[平板式和盘管式透析装置中超滤的调节]

Minerva Med. 1974 Nov 24;65(84):4372-7.

Advances in dialysis: hemodialysis membranes.透析进展：血液透析膜

Kidney Int Suppl. 1980 Sep;10:S19-25.

Purification and concentration by ultrafiltration.

Methods Mol Biol. 1996;59:115-34. doi: 10.1385/0-89603-336-8:115.

Detrimental effects of ultrafiltration on diffusion in coils.超滤对盘管中扩散的有害影响。

J Lab Clin Med. 1976 Mar;87(3):435-42.

Zeta potential of hollow fiber dialysis membranes and its effects on hydrogen phosphate ion permeability.中空纤维透析膜的ζ电位及其对磷酸氢根离子渗透性的影响。

ASAIO J. 1993 Jul-Sep;39(3):M301-4.

[The use of an ultrafiltration control monitor in patients treated with intermittent hemodialysis (proceedings)].[间歇性血液透析治疗患者中使用超滤控制监测器（会议记录）]

J Urol Nephrol (Paris). 1979 Apr-May;85(4-5):340.

引用本文的文献

Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.儿童连续肾脏替代治疗中常用药物的药代动力学：当前文献的系统评价。

Clin Pharmacokinet. 2022 Feb;61(2):189-229. doi: 10.1007/s40262-021-01085-z. Epub 2021 Nov 30.

Proteomic Investigations into Hemodialysis Therapy.血液透析治疗的蛋白质组学研究

Int J Mol Sci. 2015 Dec 10;16(12):29508-21. doi: 10.3390/ijms161226189.

In silico ordinary differential equation/partial differential equation hemodialysis model estimates methadone removal during dialysis.计算机模拟的常微分方程/偏微分方程血液透析模型可估算透析期间美沙酮的清除率。

J Pain Res. 2015 Jul 22;8:417-29. doi: 10.2147/JPR.S84615. eCollection 2015.

Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis.蛋白质组学研究不同膜材料对血液蛋白在血液透析过程中吸附的影响。

Blood Transfus. 2012 May;10 Suppl 2(Suppl 2):s101-12. doi: 10.2450/2012.014S.

In vitro adsorption of gentamicin and netilmicin by polyacrylonitrile and polyamide hemofiltration filters.聚丙稀腈和聚酰胺血液滤过器对庆大霉素和奈替米星的体外吸附。

Antimicrob Agents Chemother. 2010 Feb;54(2):963-5. doi: 10.1128/AAC.01215-09. Epub 2009 Nov 30.

Adsorption of amikacin, a significant mechanism of elimination by hemofiltration.阿米卡星的吸附作用，这是血液滤过清除药物的一个重要机制。

Antimicrob Agents Chemother. 2008 Mar;52(3):1009-13. doi: 10.1128/AAC.00858-07. Epub 2007 Dec 17.

Drug dosing during intermittent hemodialysis and continuous renal replacement therapy : special considerations in pediatric patients.间歇性血液透析和连续性肾脏替代治疗期间的药物剂量：儿科患者的特殊考量

Paediatr Drugs. 2004;6(1):45-65. doi: 10.2165/00148581-200406010-00004.

Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations.持续肾脏替代治疗患者的药物剂量。药代动力学及治疗方面的考量。

Clin Pharmacokinet. 1993 May;24(5):362-79. doi: 10.2165/00003088-199324050-00002.

Clinical pharmacokinetics during continuous haemofiltration.持续血液滤过期间的临床药代动力学

Clin Pharmacokinet. 1994 Jun;26(6):457-71. doi: 10.2165/00003088-199426060-00004.

Pharmacokinetics of continuous renal replacement therapy.

Intensive Care Med. 1995 Jul;21(7):612-20. doi: 10.1007/BF01700172.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验